The paper uses a real option approach to investigate the impact of performance-based risk-sharing agreements for the reimbursement of new drugs in comparison with standard cost-effectiveness thresholds. The results show that the exact definition of the risk-sharing agreement is key in...

Purpose The survey at hand explores the factors describing the consumers’ profile in the pharmaceutical markets of three European nations Design/methodology/approach A primary research was carried out using questionnaires with a sample of citizens (pharmacy customers) in the capital of each...

In his Labor Day address, President Biden stated that the U.S. "has the highest drug prices in the world, and there is no reason for it." For new branded drugs, the first part of that statement is supported by a recent RAND Report (Mulcahy et. al. 2021) which found U.S. average prices are 2.3...